Thus, a combination of REG4 with CA125 and HE4 could provide a more comprehensive marker panel for preoperative diagnosis of potentially neoplastic ovarian masses, and enable distinction of mucinous ovarian cancer from other ovarian cancer histotypes. The gene discussed is MUC16; the disease is ovarian carcinoma.